Sydney School of Public Health, The University of Sydney, Sydney; Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, NSW, Australia.
Sydney School of Public Health, The University of Sydney, Sydney; Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, NSW, Australia.
Am J Kidney Dis. 2020 Nov;76(5):679-689. doi: 10.1053/j.ajkd.2020.03.022. Epub 2020 May 31.
RATIONALE & OBJECTIVE: Patients with chronic kidney disease (CKD) are at an increased risk for premature death, cardiovascular disease, and burdensome symptoms that impair quality of life. We aimed to identify patient and caregiver priorities for outcomes in CKD.
Focus groups with nominal group technique.
SETTING & PARTICIPANTS: Adult patients with CKD (all stages) and caregivers in the United States, Australia, and United Kingdom.
Participants identified, ranked, and discussed outcomes that were important during the stages of CKD before kidney replacement therapy. For each outcome, we calculated a mean importance score (scale, 0-1). Qualitative data were analyzed using thematic analysis.
67 (54 patients, 13 caregivers) participated in 10 groups and identified 36 outcomes. The 5 top-ranked outcomes for patients were kidney function (importance score, 0.42), end-stage kidney disease (0.29), fatigue (0.26), mortality (0.25), and life participation (0.20); and for caregivers, the top 5 outcomes were life participation (importance score, 0.38), kidney function (0.37), mortality (0.23), fatigue (0.21), and anxiety (0.20). Blood pressure, cognition, and depression were consistently ranked in the top 10 outcomes across role (patient/caregiver), country, and treatment stage. Five themes were identified: re-evaluating and reframing life, intensified kidney consciousness, battling unrelenting and debilitating burdens, dreading upheaval and constraints, and taboo and unspoken concerns.
Only English-speaking participants were included.
Patients and caregivers gave highest priority to kidney function, mortality, fatigue, life participation, anxiety, and depression. Consistent reporting of these outcomes in research may inform shared decision making based on patient and caregiver priorities in CKD.
慢性肾脏病(CKD)患者过早死亡、心血管疾病以及影响生活质量的各种不适症状的风险较高。本研究旨在确定 CKD 患者及其照护者对结局的重视程度。
包含名义团体技术的焦点小组。
美国、澳大利亚和英国的成年 CKD(所有阶段)患者及其照护者。
参与者确定、排序并讨论了在接受肾脏替代治疗之前 CKD 各阶段重要的结局。对于每个结局,我们计算了平均重要性评分(0-1 分)。使用主题分析法对定性数据进行分析。
共有 67 名(54 名患者,13 名照护者)参与者参加了 10 个小组,并确定了 36 个结局。患者排名前 5 的结局为肾功能(重要性评分 0.42)、终末期肾病(0.29)、乏力(0.26)、死亡(0.25)和生活参与度(0.20);照护者排名前 5 的结局为生活参与度(重要性评分 0.38)、肾功能(0.37)、死亡(0.23)、乏力(0.21)和焦虑(0.20)。在不同角色(患者/照护者)、国家和治疗阶段,血压、认知和抑郁始终排在前 10 位。确定了 5 个主题:重新评估和调整生活,增强对肾脏的关注,与持续存在且使人虚弱的负担作斗争,担心剧变和限制,以及禁忌和未言明的担忧。
仅纳入了讲英语的参与者。
患者和照护者最重视肾功能、死亡率、乏力、生活参与度、焦虑和抑郁。在 CKD 研究中一致报告这些结局,可能会根据患者和照护者的需求来告知基于共同决策的决策。